Axcelis Technologies, Inc. (NASDAQ:ACLS) Given Consensus Rating of “Hold” by Analysts

Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) have been given a consensus rating of “Hold” by the six brokerages that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $130.25.

Several research analysts have recently weighed in on ACLS shares. B. Riley Financial raised shares of Axcelis Technologies from a “neutral” rating to a “buy” rating and set a $150.00 price target on the stock in a report on Monday, April 20th. Bank of America lifted their price objective on Axcelis Technologies from $130.00 to $156.00 and gave the company an “underperform” rating in a research note on Tuesday, June 23rd. Weiss Ratings cut Axcelis Technologies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, May 12th. Finally, Zacks Research upgraded Axcelis Technologies from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th.

Insiders Place Their Bets

In other news, EVP Gerald M. Blumenstock sold 1,161 shares of the stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $152.70, for a total value of $177,284.70. Following the transaction, the executive vice president owned 20,493 shares of the company’s stock, valued at $3,129,281.10. This represents a 5.36% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Eileen Evans sold 926 shares of the stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $155.51, for a total transaction of $144,002.26. Following the completion of the transaction, the executive vice president directly owned 31,295 shares in the company, valued at $4,866,685.45. The trade was a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 34,795 shares of company stock valued at $5,344,383 over the last three months. Corporate insiders own 0.49% of the company’s stock.

Institutional Trading of Axcelis Technologies

A number of hedge funds have recently made changes to their positions in ACLS. Parallel Advisors LLC grew its position in Axcelis Technologies by 22.0% during the 1st quarter. Parallel Advisors LLC now owns 665 shares of the semiconductor company’s stock worth $62,000 after acquiring an additional 120 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Axcelis Technologies by 29.7% in the third quarter. EverSource Wealth Advisors LLC now owns 585 shares of the semiconductor company’s stock valued at $57,000 after purchasing an additional 134 shares during the last quarter. Larson Financial Group LLC boosted its stake in shares of Axcelis Technologies by 17.8% during the fourth quarter. Larson Financial Group LLC now owns 933 shares of the semiconductor company’s stock valued at $75,000 after purchasing an additional 141 shares during the period. CWM LLC boosted its stake in shares of Axcelis Technologies by 5.8% during the fourth quarter. CWM LLC now owns 2,623 shares of the semiconductor company’s stock valued at $211,000 after purchasing an additional 143 shares during the period. Finally, Empowered Funds LLC grew its holdings in shares of Axcelis Technologies by 0.5% in the first quarter. Empowered Funds LLC now owns 39,087 shares of the semiconductor company’s stock worth $3,638,000 after purchasing an additional 199 shares during the last quarter. 89.98% of the stock is owned by institutional investors.

Axcelis Technologies Stock Performance

NASDAQ:ACLS opened at $178.33 on Friday. The business’s fifty day moving average is $160.41 and its 200 day moving average is $115.26. The firm has a market cap of $5.48 billion, a price-to-earnings ratio of 55.55, a PEG ratio of 13.41 and a beta of 1.87. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.99 and a current ratio of 4.59. Axcelis Technologies has a 52-week low of $65.64 and a 52-week high of $193.78.

Axcelis Technologies (NASDAQ:ACLS) last posted its earnings results on Thursday, May 7th. The semiconductor company reported $0.72 earnings per share for the quarter, topping analysts’ consensus estimates of $0.71 by $0.01. Axcelis Technologies had a net margin of 11.93% and a return on equity of 12.19%. The business had revenue of $198.96 million for the quarter, compared to analyst estimates of $195.03 million. During the same quarter in the prior year, the firm posted $0.88 EPS. Axcelis Technologies’s revenue was up 3.3% on a year-over-year basis. Axcelis Technologies has set its Q2 2026 guidance at 0.900- EPS. Research analysts predict that Axcelis Technologies will post 3.21 EPS for the current year.

About Axcelis Technologies

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.